Suppr超能文献

人血小板裂解物作为胎牛血清的无动物源替代品用于人骨髓间充质基质细胞的体外扩增

Human Platelet Lysate as a Xeno Free Alternative of Fetal Bovine Serum for the In Vitro Expansion of Human Mesenchymal Stromal Cells.

作者信息

Mohammadi Saeed, Nikbakht Mohsen, Malek Mohammadi Ashraf, Zahed Panah Mahdi, Ostadali Mohammad Reza, Nasiri Hajar, Ghavamzadeh Ardeshir

机构信息

Hematology-Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran.

School of Allied Medical Sciences, Qazvin University of Medical Sciences, Qazvin, Iran.

出版信息

Int J Hematol Oncol Stem Cell Res. 2016 Jul 1;10(3):161-71.

Abstract

BACKGROUND

Mesenchymal stromal cells (MSCs) are employed in various different clinical settings in order to modulate immune response. Human autologous and allogeneic supplements including platelet derivatives such as platelet lysate (PL), platelet-released factors (PRF) and serum are assessed in clinical studies to replace fetal bovine serum (FBS). The immunosuppressive activity and multi-potential characteristic of MSCs appear to be maintained when the cells are expanded in platelet derivatives.

MATERIALS AND METHODS

Platelet-rich plasma was collected from umbrical cord blood (UCB). Platelet-derived growth factors obtained by freeze and thaw methods. CD62P expression was determined by flow cytometry. The concentration of PDGF-BB and PDGF-AB was detemined by ELISA. We tested the ability of a different concentration of PL-supplemented medium to support the ex vivo expansion of Wharton's jelly derived MSCs. We also investigated the biological/functional properties of expanded MSCs in presence of different concentration of PL. The conventional karyotyping was performed in order to study the chromosomal stability. The gene expression of Collagen I and II aggrecan and SOX-9 in the presence of different concentrations of PL was evaluated by Real-time PCR.

RESULTS

We observed 5% and 10% PL, causing greater effects on proliferation of MSCs .These cells exhibited typical morphology, immunophenotype and differentiation capacity. The genetic stability of these derivative cells from Wharton's jelly was demonstrated by a normal karyotype. Furthermore, the results of Real-time PCR analysis showed that the expression of chondrocyte specific genes was higher in MSCs in the presence of 5% and 10% PL, compared with FBS supplement.

CONCLUSIONS

We demonstrated that PL could be used as an alternative safe source of growth factors for expansion of MSCs and also maintained similar growing potential and phenotype without any effect on chromosomal stability.

摘要

背景

间充质基质细胞(MSCs)被应用于各种不同的临床环境中以调节免疫反应。在临床研究中评估了包括血小板衍生物如血小板裂解物(PL)、血小板释放因子(PRF)和血清在内的人自体和异体补充剂,以替代胎牛血清(FBS)。当细胞在血小板衍生物中扩增时,MSCs的免疫抑制活性和多能特性似乎得以维持。

材料与方法

从脐带血(UCB)中采集富血小板血浆。通过冻融法获得血小板衍生生长因子。通过流式细胞术测定CD62P表达。通过酶联免疫吸附测定法测定血小板衍生生长因子BB(PDGF - BB)和血小板衍生生长因子AB(PDGF - AB)的浓度。我们测试了不同浓度PL补充培养基支持从沃顿胶中分离的MSCs体外扩增的能力。我们还研究了在不同浓度PL存在下扩增的MSCs的生物学/功能特性。进行常规核型分析以研究染色体稳定性。通过实时聚合酶链反应评估在不同浓度PL存在下I型和II型胶原蛋白、聚集蛋白聚糖和SRY - box 9(SOX - 9)的基因表达。

结果

我们观察到5%和10%的PL对MSCs的增殖有更大影响。这些细胞表现出典型的形态、免疫表型和分化能力。正常核型证明了这些来自沃顿胶的衍生细胞的遗传稳定性。此外,实时聚合酶链反应分析结果表明,与FBS补充剂相比,在5%和10%PL存在下,MSCs中软骨细胞特异性基因的表达更高。

结论

我们证明PL可作为MSCs扩增的替代安全生长因子来源,并且在不影响染色体稳定性的情况下保持相似的生长潜力和表型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc3d/4969561/3eac207a1e98/IJHOSCR-10-161-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验